Bone Targeted Delivery of SDF-1 via Alendronate Functionalized Nanoparticles in Guiding Stem Cell Migration
Authors:
- 25 June 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 10 (28) , 23700-23710
Abstract
Stem cells are well-known for their great capacity for tissue regeneration. This provides a promising source for cell-based therapies in treating various bone degenerative disorders. However, the major hurdles for their application in transplantation are the poor bone marrow homing and engraftment efficiencies. Stromal cell-derived factor 1 (SDF-1) has been identified as a major stem cell homing factor. With the aims of bone targeted SDF-1 delivery and regulating MSCs migration, alendronate modified liposomal nanoparticles (Aln-Lipo) carrying SDF-1 gene were developed in this study. Alendronate modification significantly increased the mineral binding affinity of liposomes, and facilitated the gene delivery to osteoblastic cells. Up-regulated SDF-1 expression in osteoblasts triggered MSCs migration. Systemic infusion of Aln-Lipo-SDF-1 with fluorescence labeling in mice showed the accumulation in osseous tissue by biophotonic imaging. Corresponding to the delivered SDF-1, the transplanted GFP+ MSCs were attracted to bone marrow and contributed to bone regeneration. This study may provide a useful technique in regulating stem cell migration.Keywords
Funding Information
- National Natural Science Foundation of China (81672226)
- Shenzhen Science and Technology Innovation Research Funding (JCYJ20160531174634936, JCYJ20170413162540673)
- Science and Technology Project of Guangdong (2016A020222007)
- Shenzhen Peacock Program (110811003586331)
This publication has 68 references indexed in Scilit:
- Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for OsteoporosisJournal of Bone and Mineral Research, 2016
- Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related OsteoporosisStem Cells Translational Medicine, 2016
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral ResearchJournal of Bone and Mineral Research, 2015
- Modulating Bone Resorption and Bone Formation in Opposite Directions in the Treatment of Postmenopausal OsteoporosisDrugs, 2015
- Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditionsMaturitas, 2014
- Stem Cells for Osteodegenerative Diseases: Current Studies and Future OutlookRegenerative Medicine, 2014
- Stem Cell Therapy for OsteoporosisCurrent Osteoporosis Reports, 2014
- Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unitBoneKEy Reports, 2014
- Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicineExperimental & Molecular Medicine, 2013
- The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicineNature Medicine, 2013